中国循证医学杂志

中国循证医学杂志

国内医院药学人员发表系统评价/Meta 分析的文献计量学分析

查看全文

目的 对国内医院药学人员发表的系统评价/Meta 分析进行文献计量学分析和质量评价。 方法 计算机检索 CNKI、WanFang Data、VIP、CBM、CMCI、PubMed、EMbase 和 The Cochrane Library(2016 年 2 期)数据库,检索时限均为建库到 2016 年 3 月 17 日。根据纳入与排除标准进行文献筛选和资料提取,并采用 PRISMA 和 AMSTAR 分别进行报告质量和方法学质量评估后,采用 Excel 2013 和 SPSS 20.0 软件进行数据统计分析。 结果 共纳入 1 018 篇系统评价/Meta 分析(中文 871 篇、英文 147 篇)。文献发表数量逐年增长,报告质量和研究质量呈现逐年增高趋势。纳入文献发表于 146 种中文期刊和 97 种英文期刊;发文作者来自 308 家单位,分布于 27 个省市。纳入研究主要评价了药物有效性与安全性,西药是药物评价的主要类别,抗肿瘤药是临床药物评价的重点。 结论 国内医院药学领域的循证药物评价发展迅速,质量呈现上升趋势,但各地发展不均衡,循证医学理念有待进一步在该领域内推广。

Objective To investigate the current status of systematic reviews/meta-analyses published by pharmacists in hospital in China by using bibliometric analysis and assessing the methodological quality of these studies. Methods The literatures were searched from CNKI, WanFang Data, VIP, CBM, CMCI, PubMed, EMbase, The Cochrane Library (Issue 2, 2016) from the establishment to March 17th, 2016. According to the inclusive and exclusive criteria, the authors independently screened literature and extracted the data. Methodology quality and reporting quality were evaluated by using AMSTAR tool and PRIMSA statement. Data analysis was conducted by using Excel 2013 and SPSS 20.0 software. Results A total of 1 018 systematic reviews/meta-analyses were included of which 871 were published in Chinese and 147 were in English. The published literature increased year by year, as well as the reporting quality and methodological quality. All of the included studies were published in 146 Chinese journals and 97 English journals. The authors were from 308 hospitals of 27 provinces. Drug effectiveness and drug safety were mainly assessed, and western medicine was the main category. Most of these studies were focused on anti-tummor drugs. Conclusion Evidenced-based drug evaluation by hospital pharmacists in China is rapidly increasing as well as the methodological quality and reporting quality, however, the development is unbalanced in China, and evidence-based medicine should be further promoted in the field of hospital pharmacy.

关键词: 系统评价; Meta 分析; 药学人员; 文献计量学

Key words: Systematic reviews; Meta-analysis; Pharmacists; Bibliometric analysis

引用本文: 周鹏翔, 闫盈盈, 翟所迪. 国内医院药学人员发表系统评价/Meta 分析的文献计量学分析. 中国循证医学杂志, 2017, 17(5): 580-586. doi: 10.7507/1672-2531.201608069 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. 张伶俐, 梁毅, 李幼平. 循证药学定义和文献的系统评价. 中国循证医学杂志, 2011, 11(1): 7-13.
2. 闫盈盈, 易湛苗, 翟所迪. 国内医院药学人员系统评价/Meta 分析文献发表与质量研究. 中国循证医学杂志, 2012, 12(1): 92-97.
3. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med, 2009, 6(6): e1000097.
4. Moher D, Liberati A, Tetzlaff J, 等. 系统综述和荟萃分析优先报告的条目: PRISMA 声明. 中西医结合学报, 2009, 9(7): 889-896.
5. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess systematic reviews. BMC Med Res Methodol, 2007, 7(10): 1-10.
6. 世界卫生组织药物政策与标准司, 国际药学联合会. 开展药学实践—以患者为中心, 2006版. Available at: .
7. 赵建彬, 陈菲菲. 从文献计量学看循证药学的发展现状. 中国职业药师, 2013, 10(7): 35-37.
8. Burkiewicz JS, Zgarrick DP. Evidence-based practice by pharmacists: utilization and barriers. Ann Pharmacotherapy, 2005, 9(7): 1214-1219.
9. 佟岩, 吴英良, 徐颖峰. 从文献计量学分析角度看我国循证药学研究. 中药药理与临床, 2012, 28(2): 196-198.
10. 邢小燕, 马永刚, 孙玉琦, 等. 循证药学在中药安全性和有效性评价中的应用. 中草药, 2006, 37(8): 1269-1271.